Showing 2,001 - 2,020 results of 18,113 for search 'significant ((((((step decrease) OR (we decrease))) OR (a decrease))) OR (small decrease))', query time: 0.67s Refine Results
  1. 2001
  2. 2002
  3. 2003

    Reagent list. by Adrienne J. Bradley (20861948)

    Published 2025
    “…We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. …”
  4. 2004

    Data for figures. by Adrienne J. Bradley (20861948)

    Published 2025
    “…We found a significant increase of Iba-1, indicative of microglia activation, although the overall levels of IL-1β, IL-6, TNFα, IL-4, IL-10, and TGFβ mRNA transcripts were not different between the treatment groups. …”
  5. 2005
  6. 2006
  7. 2007

    Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

    Published 2025
    “…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”
  8. 2008
  9. 2009

    S1 Raw data - by Muhammad Naeem Sattar (19828497)

    Published 2024
    “…The larval duration was also decreased significantly in the larvae treated with all the dsRNA treatments. …”
  10. 2010
  11. 2011
  12. 2012

    <b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

    Published 2025
    “…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”
  13. 2013
  14. 2014
  15. 2015

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
  16. 2016
  17. 2017
  18. 2018
  19. 2019
  20. 2020